Kangpu Bio-Pharma is a clinical stage company.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Shanghai
State: Shanghai
Zip:
Country: China
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2019 | Series A | 3 | $14M |
Furong Capital Northern Light Venture Capital Shenzhen Guozhong Venture Capital Management Furong Capital Northern Light Venture Capital Shenzhen Guozhong Venture Capital Management |
5/2021 | Series B | $0 |
ABC International Lapam Capital Ruihe Venture Capital Shining Capital Yijing Capital Zhongguancun Kaiyuan Capital ABC International Lapam Capital Ruihe Venture Capital Shining Capital Yijing Capital Zhongguancun Kaiyuan Capital |
5/2021 | Series B | 6 | $39M |
ABC International Lapam Capital Ruihe Venture Capital Shining Capital Yijing Capital Zhongguancun Kaiyuan Capital ABC International Lapam Capital Ruihe Venture Capital Shining Capital Yijing Capital Zhongguancun Kaiyuan Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|